All data are based on the daily closing price as of October 9, 2026
u
Universal Vision Biotechnology
3218.TWO
4.16 USD
-0.03
-0.72%
Overview
Last close
4.16 usd
Market cap
352.84M usd
52 week high
7.46 usd
52 week low
3.93 usd
Target price
4.7 usd
Valuation
P/E
9.8811
Forward P/E
40.4858
Price/Sales
2.6364
Price/Book Value
2.9198
Enterprise Value
369.47M usd
EV/Revenue
2.7583
EV/EBITDA
5.8615
Key financials
Revenue TTM
133.95M usd
Gross Profit TTM
77.94M usd
EBITDA TTM
53.16M usd
Earnings per Share
0.42 usd
Dividend
0.24 usd
Total assets
201.28M usd
Net debt
N/A usd
About
Universal Vision Biotechnology Co., Ltd., a biotech company, provides vision care services in Taiwan and China. The company offers various glasses and lenses for vision correction, contact lens solutions, and related eye care products; equipment rental and technical services for laser vision correction instruments; and technology and services for cataract and dry eye examination and treatment instruments. It also trades in medical and pharmaceutical consumables, including ophthalmic drugs, medical supplies, and consumables; and provides administrative and other professional logistics support services for cooperative clinics and eye centers, as well as brand licensing and consulting services. The company offers its products through its self-operated eyeglasses stores. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.